LDS/Medical Tests/DKC1 Gene Mutation Analysis

DKC1 Gene Mutation Analysis

Chromosomal telomeres are maintained by two important protein complexes, telomerase and shelterin. Telomerase counteracts the shortening of telomeres by adding small repeated segments of DNA to the ends of chromosomes each time the cell divides. One component of telomerase, called hTR, provides a template for creating the repeated DNA sequence that telomerase adds to the ends of chromosomes. The DKC1 gene located on the long (q) arm of the X chromosome at position 28 encodes dyskerin protein that binds to hTR and helps stabilize the telomerase complex. Dyskerin is also involved in the production of ribosomal RNA (rRNA) that is required for assembling amino acids into proteins.

The X-linked form of Dyskeratosis congenita is caused by the mutations in DKC1 gene. It is characterized by the classic triad of lacy pigmentation of the upper chest and neck, oral leukoplakia and dystrophic nails. In addition, patients with dyskeratosis congenita have an increased risk of developing pulmonary fibrosis, myelodysplasia, acute leukemia, bone marrow failure and several types of cancer.

  • Diagnostic confirmation of DKC1-associated dyskeratosis congenita
  • For the carrier testing of family members of the affected patient
  • For the prenatal diagnosis in at-risk pregnancies

Positive: Mutation or pathogenic variant in DKC1 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative: No mutation or pathogenic variant in DKC1 gene.

Negative for mutation or pathogenic variant in DKC1 gene

Sequence analysis by next generation sequencing or bi-directional sequencing. DKC1 gene-targeted deletion/duplication analysis detects intragenic deletions or duplications by quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), Comparative genomic hybridization.

Whole blood, Cultured cells, Skin biopsy.

Stability (blood)

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Dyskeratosis Congenita Gene Panel, Telomere Defects Gene Panel, pathogenic variants analysis in ACD, PARN, CTC1, NHP2, NOP10, RTEL1, TERT, TINF2 USB1 (C16ORF57), and WRAP53 (TCAB1) genes, bone marrow biopsy.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login